Liver Diseases  >>  Sovaldi (sofosbuvir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sovaldi (sofosbuvir) / Gilead
STEADFAST, NCT01994486: Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

Completed
2
20
US
Telaprevir and Sofosbuvir, TVR, SOF
University of Florida, Vertex Pharmaceuticals Incorporated
Hepatitis C, Chronic
04/14
09/14

Download Options